Novartis, life sciences firms collaborate with BMGF to fight against COVID-19 disease

This article was originally published here

Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck, Pfizer, Sanofi, BD and bioMérieux are part of the consortium. The firms are working

The post Novartis, life sciences firms collaborate with BMGF to fight against COVID-19 disease appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply